Improvements in Systemic Therapies for Advanced Malignant Mesothelioma

Improvements in Systemic Therapies for Advanced Malignant Mesothelioma

Malignant pleural mesothelioma (MPM) is a rare and aggressive malignancy associated with poor prognosis and a 5-year survival rate of 12%. Many drugs have been tested over the years with conflicting results. The aim of this review is to provide an overview of current therapies in MPM and how to best...

Full description

Bibliographic Details
Main Authors:	Chiara Deiana, Francesca Fabbri, Simona Tavolari, Andrea Palloni, Giovanni Brandi
Format:	Article
Language:	English
Published:	MDPI AG 2023-06-01
Series:	International Journal of Molecular Sciences
Subjects:	mesothelioma advanced mesothelioma systemic therapies novel approaches immunotherapy target therapy
Online Access:	https://www.mdpi.com/1422-0067/24/13/10415

Similar Items

Oncological Frontiers in the Treatment of Malignant Pleural Mesothelioma
by: Emanuele Vita, et al.
Published: (2021-05-01)

An Update on Emerging Therapeutic Options for Malignant Pleural Mesothelioma
by: Davis A, et al.
Published: (2022-03-01)

Systematic Analysis of Aberrant Biochemical Networks and Potential Drug Vulnerabilities Induced by Tumor Suppressor Loss in Malignant Pleural Mesothelioma
by: Haitang Yang, et al.
Published: (2020-08-01)

Local Therapies and Modulation of Tumor Surrounding Stroma in Malignant Pleural Mesothelioma: A Translational Approach
by: Daniela Lisini, et al.
Published: (2021-08-01)

Investigational approaches for mesothelioma
by: Veerle F Surmont, et al.
Published: (2011-08-01)

The Role of Immunotherapy in the Treatment of Malignant Pleural Mesothelioma
by: Shantanu Banerji, et al.
Published: (2021-11-01)

Molecular Fingerprints of Malignant Pleural Mesothelioma: Not Just a Matter of Genetic Alterations
by: Eugenia Lorenzini, et al.
Published: (2021-06-01)

Relapse Patterns and Tailored Treatment Strategies for Malignant Pleural Mesothelioma Recurrence after Multimodality Therapy
by: Alice Bellini, et al.
Published: (2021-03-01)

Advances in Immunotherapy for Malignant Pleural Mesothelioma
by: Yujia CHI, et al.
Published: (2022-04-01)

Tumor Immune Microenvironment and Genetic Alterations in Mesothelioma
by: Stefanie Hiltbrunner, et al.
Published: (2021-06-01)

Diffuse Peritoneal Malignant Mesothelioma Presenting with Abnormal Uterine Bleeding: Case Report
by: Ivana Rizzuto, et al.
Published: (2022-03-01)

The Rocky Road from Preclinical Findings to Successful Targeted Therapy in Pleural Mesothelioma
by: Juuso Paajanen, et al.
Published: (2022-11-01)

Long term survival after trimodal therapy in malignant pleural mesothelioma
by: René Fahrner, et al.
Published: (2012-10-01)

Current status and progress in immunotherapy for malignant pleural mesothelioma
by: Boyang Sun, et al.
Published: (2022-06-01)

The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma
by: Maxime Borgeaud, et al.
Published: (2023-02-01)

Inhibition of Human Malignant Pleural Mesothelioma Growth by Mesenchymal Stromal Cells
by: Valentina Coccè, et al.
Published: (2021-06-01)

Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma
by: Jacopo Moro, et al.
Published: (2022-12-01)

Secondary Malignant Peritoneal Mesothelioma of the Greater Omentum after Therapy for Primary Pleural Mesothelioma
by: Andreas Gutzeit, et al.
Published: (2013-04-01)

The Current Treatment Landscape of Malignant Pleural Mesothelioma and Future Directions
by: Beatriz Bertin, et al.
Published: (2023-12-01)

Curcumin as an Anticancer Agent in Malignant Mesothelioma: A Review
by: Alfonso Baldi, et al.
Published: (2020-03-01)

The Genes–Stemness–Secretome Interplay in Malignant Pleural Mesothelioma: Molecular Dynamics and Clinical Hints
by: Giulia M. Stella, et al.
Published: (2023-02-01)

Editorial: Novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models
by: Sze-Kwan Lam, et al.
Published: (2022-09-01)

Response to Immune Checkpoint Inhibitor Therapy in Patients with Unresectable Recurrent Malignant Pleural Mesothelioma Shown by FDG-PET and CT
by: Kazuhiro Kitajima, et al.
Published: (2021-03-01)

Current State-of-the-Art Therapy for Malignant Pleural Mesothelioma and Future Options Centered on Immunotherapy
by: Susana Cedres, et al.
Published: (2023-12-01)

Evaluation of prognostic histological parameters proposed for pleural mesothelioma in diffuse malignant peritoneal mesothelioma. A short report
by: Federica Pezzuto, et al.
Published: (2021-07-01)

Water-Soluble Truncated Fatty Acid–Porphyrin Conjugates Provide Photo-Sensitizer Activity for Photodynamic Therapy in Malignant Mesothelioma
by: Sam Bonsall, et al.
Published: (2022-11-01)

Emerging New Targets in Systemic Therapy for Malignant Pleural Mesothelioma
by: Karen M. Yun, et al.
Published: (2024-03-01)

Clinical Next Generation Sequencing Application in Mesothelioma: Finding a Golden Needle in the Haystack
by: Luigi Cerbone, et al.
Published: (2023-12-01)

TGFα Promotes Chemoresistance of Malignant Pleural Mesothelioma
by: Bernard Staumont, et al.
Published: (2020-06-01)

Highlighting the immunohistochemical differences of malignant mesothelioma subtypes via case presentations
by: Anita Sejben, et al.
Published: (2023-04-01)

Important functional role of the protein osteopontin in the progression of malignant pleural mesothelioma
by: Elisabeth Digifico, et al.
Published: (2023-06-01)

Mesothelioma of tunica vaginalis of "uncertain malignant potential" - an evolving concept: case report and review of the literature
by: Yilmaz Asli, et al.
Published: (2011-08-01)

The role of CD24 as a potential biomarker for malignant pleural mesothelioma
by: Mohamed Shaaban Mousa, et al.
Published: (2023-01-01)

Radiological evaluation of malignant pleural mesothelioma - defining distant metastatic disease
by: Dearbhaile Catherine Collins, et al.
Published: (2020-12-01)

Interobserver Agreement in Histopathological Subtyping of Malignant Pleural Mesotheliomas
by: Mona MLIKA, et al.
Published: (2021-01-01)

Unusual Histology in Mesothelioma: A Report of Two Cases with a Brief Review
by: Francesca Bono, et al.
Published: (2022-02-01)

Malignant Mesothelioma in Cappadocia: Data from Eight Regional Hospitals
by: İpek Pınar Aral, et al.
Published: (2020-09-01)

Malignant mesothelioma
by: Suzanne Alkul, et al.
Published: (2016-04-01)

Novel and Future Treatment Options in Mesothelioma: A Systematic Review
by: Danijela Štrbac, et al.
Published: (2022-02-01)

Hitting the Bull’s-Eye: Mesothelin’s Role as a Biomarker and Therapeutic Target for Malignant Pleural Mesothelioma
by: Dannel Yeo, et al.
Published: (2021-08-01)